Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Growth

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 50.42365.23-83.7020.61100.96

What is the latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE is 50.42 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202450.42
Mar2023365.23
Mar2022-83.70
Mar202120.61
Mar2020100.96

How is Core EBITDA Growth of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Growth % Change
Mar2024 50.42
-86.20
Mar2023 365.23
Positive
Mar2022 -83.7
Negative
Mar2021 20.61
-79.59
Mar2020 100.96 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Growth ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹6,886.4 Cr 12.3% 15.4% 2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹163,010.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹118,905.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,523.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹100,015.0 Cr 3.2% -1% 27.4% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

12.3%

15.4%

2.8%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses